Inventor · disambiguated record
Carolyn Diane Dzierba
Also filed as: DZIERBA CAROLYN · DZIERBA CAROLYN DIANE
30 granted patents·8 pending applications·55 citations·filing 1999–2024
94Inventor score
Top patents by PatentIndex Score
38 records- 0197US9902722B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Feb 27, 2018·19 cites·13 claims
- 0295US11767322B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 26, 2023·3 cites·66 claims
- 0393US10913738B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 9, 2021·7 cites·14 claims
- 0491US10155760B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Dec 18, 2018·3 cites·4 claims
- 0590US10723734B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 28, 2020·2 cites·1 claims
- 0689US2024360131A1Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0781US11440913B2Aminoimidazopyridazines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Sep 13, 2022·2 cites·14 claims
- 0879US12110290B2Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Oct 8, 2024·0 cites·14 claims
- 0979US10544120B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 28, 2020·2 cites·3 claims
- 1079US2025074909A1Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1178US12065437B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Aug 20, 2024·0 cites·4 claims
- 1278US2024425505A1Triazolopyridinyl compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1376US10253027B2Aryl lactam kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Apr 9, 2019·3 cites·6 claims
- 1476US9708337B2Aryl amide-based kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jul 18, 2017·3 cites·10 claims
- 1575US10981910B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 20, 2021·0 cites·2 claims
- 1671US10246469B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 2, 2019·1 cites·8 claims
- 1769US8703953B2Aryl ether-base kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 22, 2014·1 cites·8 claims
- 1868US7067658B2Pyridino and pyrimidino pyrazinonesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jun 27, 2006·6 cites·60 claims
- 1967US12157733B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Dec 3, 2024·0 cites·6 claims
- 2067US8901305B2Aryl lactam kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Dec 2, 2014·1 cites·11 claims
- 2165US9932320B2Quinoline-based kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Apr 3, 2018·1 cites·10 claims
- 2260US2024190890A1Mk2 inhibitors and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 2359US8304577B2Modulators of G protein-coupled receptor 88DZIERBA CAROLYN DIANE·Filed 2010·Granted Nov 6, 2012·1 cites·4 claims
- 2455US12275721B2Indazole carboxamides as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 15, 2025·0 cites·12 claims
- 2554US2016199372A1Imidazopyridazine kinase inhibitors useful to treating a disease or disorder mediated by aak1, such as alzheimer's disease, bipolar disorder, pain, schizophreniaBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 2653US8969564B2Aryl ether-base kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 3, 2015·0 cites·3 claims
- 2751US12084426B2Indazole carboxamides as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Sep 10, 2024·0 cites·13 claims
- 2848US12172975B21H-indazole carboxamides as receptor-interacting protein kinase 1 inhibitors (RIPK1)BRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 24, 2024·0 cites·12 claims
- 2946US9737542B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 22, 2017·0 cites·7 claims
- 3044US11618753B2Aminopyrrolotriazines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 4, 2023·0 cites·9 claims
- 3143US2016222021A1Aryl ether-base kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 3243US2016333006A1Aryl lacta kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 3337US10174044B2Fused pyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 8, 2019·0 cites·12 claims
- 3435US10035777B2Heterocyclic kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 31, 2018·0 cites·12 claims
- 3535US2017239249A1Quinazoline-based kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 3634US8497271B2Modulators of G protein-coupled receptor 88BI YINGZHI·Filed 2010·Granted Jul 30, 2013·0 cites·15 claims
- 3734US8426414B2Modulators of G protein-coupled receptor 88BI YINGZHI·Filed 2010·Granted Apr 23, 2013·0 cites·7 claims
- 3823US6693168B1Chiral cyanoamines and methods of preparationTRUSTEES BOSTON COLLEGE·Filed 1999·Granted Feb 17, 2004·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Carolyn Diane Dzierba files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →